Skip to content
  • Tuesday, 29 September 2026
  • 11:33 am
  • Follow Us
Lab DB
  • Home
  • About Us
    • About Us
    • Affiliate Disclosure
    • Cookie Policy
    • Disclaimer
    • Privacy Policy
    • DMCA
    • Terms of Service
  • Contact Us
  • FAQ
  • Home
  • CNPV: A gamechanger for the pharma industry or simply more chaos?
Laboratory Automation & Robotics

CNPV: A gamechanger for the pharma industry or simply more chaos?

Lana Keisha Jul 19, 2026 0

The pharmaceutical industry finds itself at a pivotal juncture with the advent of the U.S. Food and Drug Administration’s (FDA)…

Read More
Laboratory Automation & Robotics

CNPV: A gamechanger for the pharma industry or simply more chaos?

Lana Keisha Jul 12, 2026 0

The United States Food and Drug Administration (FDA) embarked on a pivotal initiative in June 2025 with the announcement of…

Read More
Laboratory Automation & Robotics

CNPV: A gamechanger for the pharma industry or simply more chaos?

Lana Keisha Jul 4, 2026 0

The United States Food and Drug Administration (FDA) embarked on a bold new initiative in June 2025 with the announcement…

Read More
Laboratory Automation & Robotics

CNPV: A gamechanger for the pharma industry or simply more chaos?

Lana Keisha Jun 27, 2026 0

The pharmaceutical industry finds itself at a pivotal juncture with the advent of the U.S. Food and Drug Administration’s (FDA)…

Read More
Laboratory Automation & Robotics

CNPV: A gamechanger for the pharma industry or simply more chaos?

Lana Keisha Jun 20, 2026 0

The U.S. Food and Drug Administration (FDA) launched its Commissioner’s National Priority Voucher (CNPV) pilot program in June 2025, an…

Read More
Science News: A Century of Independent Scientific Journalism and Public EngagementPart 1: The Patient Still Needs a CBC: How the CDC Changed the Way We Think About Testing Patients with Ebola and Other Viral Hemorrhagic FeversDecoding the Transcriptome: Innovative Frontiers in RNA Processing Research and Tumor BiologySmall study suggests probiotic yogurt strain may boost immunotherapy response in lung cancer
Japan’s FY26 NHI Drug Price Revision: Deeper Dive into Mechanisms and Market ImpactThe Most Favored Nation (MFN) Policy’s Unforeseen Ripple Effect: European Pharmaceutical Launches and Withdrawals PlummetMEDVi Under Scrutiny: AI-Powered Telehealth Startup Faces FDA Warnings, Deceptive Marketing Allegations, and Multiple Lawsuits Despite Meteoric GrowthLLMOps in 2026: The 10 Tools Every Team Must Have
Dual-Drug Therapy Breakthrough Offers New Hope for Acute Myelogenous Leukemia Patients in Landmark Ludwig Cancer Research StudyMolten Salt Breakthrough: Oak Ridge Researchers Convert Common Plastic Waste Into Gasoline and Diesel at Low TemperaturesDaiichi Sankyo and Merck Voluntarily Withdraw US Application for Lung Cancer Drug Ifinatamab Deruxtecan Following FDA DiscussionsScience News: A Century of Independent Scientific Journalism and the Evolution of Public Literacy
YOU MAY HAVE MISSED
Stem Cell & Regenerative Medicine
Dual-Drug Therapy Breakthrough Offers New Hope for Acute Myelogenous Leukemia Patients in Landmark Ludwig Cancer Research Study
Dwi Wanna Sep 29, 2026
Advanced Materials Science
Molten Salt Breakthrough: Oak Ridge Researchers Convert Common Plastic Waste Into Gasoline and Diesel at Low Temperatures
Nila Kartika Wati Sep 29, 2026
Pharmaceutical R&D
Daiichi Sankyo and Merck Voluntarily Withdraw US Application for Lung Cancer Drug Ifinatamab Deruxtecan Following FDA Discussions
Teuku Ryan Sep 29, 2026
Environmental & Analytical Chemistry
Science News: A Century of Independent Scientific Journalism and the Evolution of Public Literacy
Abdurrohim Arsyad Sep 29, 2026

Copyright © 2026 | Powered by WordPress | News Gadgets by ThemeArile

  • Home
  • About Us
    • About Us
    • Affiliate Disclosure
    • Cookie Policy
    • Disclaimer
    • Privacy Policy
    • DMCA
    • Terms of Service
  • Contact Us
  • FAQ